{"prompt": "['Boehringer Ingelheim', '16 Dec 2019', 'BI Trial No.: 1199-0324', 'c19558808-06', 'Clinical Trial Protocol', 'Page 66 of 103', 'Proprietary confidential information \u00a9 2019 Boehringer Ingelheim International GmbH or one or more of its affiliated companies', '01-MCS-40-106-RD-03 (14.0) / Saved on: 17 October 2016']['Boehringer Ingelheim', '16 Dec 2019', 'BI Trial No.: 1199-0324', 'c19558808-06', 'Clinical Trial Protocol', 'Page 67 of 103', 'Proprietary confidential information \u00a9 2019 Boehringer Ingelheim International GmbH or one or more of its affiliated companies', '10.2', 'MODIFIED BORG SCALE (MBS-S)', 'R14-0975', 'PATIENT INSTRUCTIONS', 'The Borg Scale is used to help us understand the intensity or severity of your breathlessness and', 'the intensity or severity of your fatigue. We will ask you to use this scale to rate the intensity of', 'your breathlessness and your fatigue before, during, and after your exercise test.', 'Please review the scale to see the various levels from which you can choose.', 'For breathlessness (dyspnea):', 'The top of the scale, \"0 or nothing at all,\" means no breathlessness at all.', 'The bottom of the scale, \"10 or maximal,\" means the most severe breathlessness that you have', 'ever experienced or could imagine experiencing.', 'For fatigue:', 'The top of the scale, \"0 or nothing at all,\" means no fatigue at all.', 'The bottom of the scale, \"10 or maximal,\" means the most severe fatigue that you have ever', 'experienced or could imagine experiencing.', 'When we ask you to rate the intensity of your breathlessness and your fatigue, please place the tip', 'of your finger on the number that best describes the intensity that you are experiencing at that', 'moment. You may also place a finger between 2 numbers if that better describes the intensity of', 'your breathlessness or your fatigue.', 'Please let us know if you have any questions before we begin.', '0', 'Nothing at all', '0.5', 'Very, very slight (just noticeable)', '1', 'Very slight', '2', 'Slight', '3', 'Moderate', '4', 'Somewhat severe', '5', 'Severe', '6', '7', 'Very severe', '8', '9', 'Very, very severe (almost maximal)', '10', 'Maximal', '01-MCS-40-106-RD-03 (14.0) / Saved on: 17 October 2016']['Boehringer Ingelheim', '16 Dec 2019', 'BI Trial No.: 1199-0324', 'c19558808-06', 'Clinical Trial Protocol', 'Page 68 of 103', 'Proprietary confidential information \u00a9 2019 Boehringer Ingelheim International GmbH or one or more of its affiliated companies', 'Study Specific Instructions for the Borg Scale', 'Prior to the start of exercise test, each subject will be told that they will be asked to rate the', 'intensity of 2 sensations at rest, during exercise, and at end-exercise. The 2 sensations will be', 'described to the subject as:', '- Shortness of breath (dyspnea or breathlessness)', '- Fatigue', 'Use of the Borg Scale to rate these sensations will be explained to the subject. While showing', 'the scale to the subject, the study coordinator or blinded tester will explain that the subject', 'should relate the wording on the Borg Scale to the level of the sensation that he / she is', 'experiencing, and then place the end of a finger on a number that best describes the intensity', 'of the sensation - explain that placing a finger between 2 numbers is allowed. (Borg Scale', 'numbers will be recorded to the nearest 0.5 units).', 'The study coordinator or blinded tester will anchor the endpoints of the scale for both', 'sensations. The study coordinator or blinded tester will explain that for the sensation of', '\"shortness of breath\", \"0 or nothing at all\" corresponds to \"no shortness of breath\" and \"10 or', 'maximal\" corresponds to the \"worst imaginable shortness of breath\". The study coordinator', 'or blinded tester will then explain that for the sensation of \"fatigue\", \"0 or nothing at all\"', 'again corresponds to \"no fatigue\" and \"10 or maximal\" corresponds to the \"worst imaginable', 'fatigue\".', 'Subjects are to be given no further information about these sensations. If a subject requests', 'further clarification, he/she will be told to use his/her own individual interpretation as to the', 'meaning of the sensory descriptors. This will ensure that the sensory descriptors are presented', 'to each subject in a standard format.', '10.3', \"ST. GEORGE'S RESPIRATORY QUESTIONNAIRE (SGRQ)\", \"What is the St George's Respiratory Questionnaire?\", 'The SGRQ is designed to measure health impairment in patients with asthma and COPD. It is', 'also valid for use in bronchiectasis and has been used successfully in patients with', 'kyphoscoliosis and sarcoidosis. It is not suitable for cystic fibrosis. It is in two parts. Part I', 'produces the Symptoms score, and Part 2 the Activity and Impacts scores. A Total score is', 'also produced.', \"Part 1 (Questions 1 to 8) covers the patients' recollection of their symptoms over a preceding\", 'period that may range 1 month to 1 year. It is not designed to be an accurate epidemiological', \"tool; its purpose is to assess the patient's perception of their recent respiratory problems. The\", 'original version was validated using a 12-month recall period. More recently a 1 month recall', 'version (appropriately worded) has been validated. This has slightly weaker psychometric', 'properties than the 12-month version and produces a marginally lower Symptom score and', 'Total score. A 3-month recall period has been used very satisfactorily. In summary, the 3-', 'month and 1-year versions provide the best properties, with no specific advantages to either.', 'The 1-month version should only be used when the time frame of the study dictates.', '01-MCS-40-106-RD-03 (14.0) / Saved on: 17 October 2016']\n\n###\n\n", "completion": "END"}